Title : Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.

Pub. Date : 1999 May

PMID : 10423656






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 After 12 weeks of treatment, both drugs demonstrated a significant decrease from baseline in high-density lipoprotein (HDL) apolipoprotein A-I (HDL-apoA-I) (nebivolol, P <.02; atenolol, P <.05). Nebivolol apolipoprotein A1 Homo sapiens
2 After 12 weeks of treatment, both drugs demonstrated a significant decrease from baseline in high-density lipoprotein (HDL) apolipoprotein A-I (HDL-apoA-I) (nebivolol, P <.02; atenolol, P <.05). Nebivolol apolipoprotein A1 Homo sapiens